title: FDA approval of obesity drugs: a difference in risk-benefit perceptions.
authors.affiliation: Department of Health Systems, Management, and Policy, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO 80045, USA. elaine.morrato@ucdenver.edu
authors.forename: Elaine H
authors.initials: EH
authors.lastname: Morrato
authors.forename: David B
authors.initials: DB
authors.lastname: Allison
mesh_terms: D019440:Anti-Obesity Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003657:Decision Making; D017277:Drug Approval; D006801:Humans; D009765:Obesity / Q000188:drug therapy*; D010465:Perception; D012306:Risk; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D019440:Anti-Obesity Agents